Saklayen 2018: Global Epidemic of Metabolic Syndrome
Saklayen • Current Hypertension Reports • 2018
Metabolic syndrome affects 25% of adults globally
Curated scientific studies with plain-English summaries and multi-paradigm interpretation
Showing 9 studies
Saklayen • Current Hypertension Reports • 2018
Metabolic syndrome affects 25% of adults globally
Younossi et al. • Hepatology • 2016
NAFLD affects approximately 25% of adults globally with highest rates in Middle East and South America.
Stark et al. • Prog Lipid Res • 2016
Most of the world has omega-3 levels below cardioprotective thresholds.
Younossi ZM, et al. • Hepatology • 2016
Global NAFLD prevalence is 25.24% (95% CI: 22.10-28.65%). Associated comorbidities: obesity 51%, hyperlipidemia 69%, hypertension 39%, type 2 diabetes 23%.
Rosanoff A et al. • Nutr Rev • 2012
Up to 50% of Americans don't meet magnesium RDA
Zhu Y, Pandya BJ, Choi HK • Arthritis Rheum • 2011
Gout and hyperuricemia affect 8.3 and 43.3 million Americans respectively
Onat et al. • Atherosclerosis • 2010
AIP independently predicts coronary heart disease in Turkish population
Allen LH • Am J Clin Nutr • 2009
B12 deficiency affects elderly, vegetarians, and malabsorption patients disproportionately
Bonora E, et al. • Diabetes Care • 2000
Both HOMA-IR and QUICKI provide reliable insulin resistance assessment in population studies, with QUICKI showing slightly better correlation with clamp in some subgroups.